News
BFRI
1.540
+33.91%
0.390
Weekly Report: what happened at BFRI last week (0318-0322)?
Weekly Report · 3d ago
Analysts’ Top Healthcare Picks: Biofrontera (BFRI), Alpine Immune Sciences (ALPN)
3 analysts have maintained a Buy rating on Biofrontera, Alpine Immune Sciences and NewAmsterdam Pharma Company. The Healthcare sector has 3 of the top 3 stocks recommended by analysts today. 3 analysts have just weighed in on the Healthcare sector with bullish sentiments for the 3 stocks.
TipRanks · 03/19 10:50
Weekly Report: what happened at BFRI last week (0311-0315)?
Weekly Report · 03/18 12:00
Biofrontera GAAP EPS of $1.65 beats by $2.79, revenue of $10.6M misses by $1.21M
Biofrontera Inc. GAAP EPS of $1.65 beats by $2.79, revenue of $10.6M misses by $1,21M in Q4. The company's Q4 revenue was down 5.0% from the same period last year.
Seeking Alpha · 03/18 04:39
BFRI Stock Earnings: Biofrontera Beats EPS, Misses Revenue for Q4 2023
Biofrontera reported earnings per share of $1.65. The company reported revenue of $10.60 million. This was 8.03% worse than the analyst estimate for revenue of $11.52 million. Biofrontera also missed revenue estimates for the quarter.
Investorplace · 03/16 01:52
Biofrontera Inc reports results for the quarter ended in December - Earnings Summary
Biofrontera Inc reports results for the quarter ended in December. Revenue rose 4.5% to $10.60 million from a year ago. The company reported a quarterly adjusted loss of $1.80 per share. Average analyst rating on the shares is "buy"
Reuters · 03/15 23:10
Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Jabil Inc. Shares dipped 14.2% to $126.56 on Friday. The company reported financial second-quarter results and issued FY25 guidance below estimates. Verb Technology Company, Inc. (NASDAQ:VERB) shares jumped 189% in today's mid-day session.
Benzinga · 03/15 18:31
VERI, STI and VERB among mid-day movers
Verb Technology Company (VERB) and Geron Corp. Among mid-day movers. Groupon, C3is and Urgently are among the companies that lost ground. VERI, STI and VERB among the biggest gainers on the day.
Seeking Alpha · 03/15 16:52
Geron, Graphite Bio, Immuneering among healthcare movers
Healthcare On the Move: Geron, Graphite Bio, Immuneering among healthcare movers. S&P 500 Health Care Sector -0.46% to 1688.46. Pharmaceuticals, Biotechnology & Life Science contributes 58% to the index.
Seeking Alpha · 03/15 14:00
Earnings Scheduled For March 15, 2024
NeoGenomics is expected to report quarterly earnings at $0.17 per share on revenue of $182.13 million. EHang Holdings is also projected to report earnings for its fourth quarter. Other companies reporting before the bell and after the bell include Prestige Consumer and Buckle.
Benzinga · 03/15 09:15
Biofrontera's Earnings Outlook
Biofrontera is set to give its latest quarterly earnings report on Friday, 2024-03-15. Analysts estimate the company will report an earnings per share of $-1.19. Last quarter the company missed EPS by $0.38. The company's shares are down 86.85% in the last 52 weeks.
Benzinga · 03/14 15:01
Biofrontera Inc <BFRI.OQ> expected to post a loss of $1.19 a share - Earnings Preview
Biofrontera Inc expected to post a loss of $1.19 a share - Earnings Preview. The company is expected to report a 13.6% increase in quarterly revenue to $11.522 million from $10.14 million.
Reuters · 03/13 20:03
Biofrontera files to sell 9.31M shares of common stock for holders
Biofrontera files to sell 9.31M shares of common stock for holders Mar. 11, 2024. The company filed a prospectus related to the proposed resale of 9. 31 million common shares. This prospectus is not an offer to sell these securities.
Seeking Alpha · 03/11 15:44
Weekly Report: what happened at BFRI last week (0304-0308)?
Weekly Report · 03/11 11:55
12 Health Care Stocks Moving In Thursday's After-Market Session
Ainos (NASDAQ:AIMD) shares moved upwards by 100.0% to $2.24 during Thursday's after-market session. Unicycive Therapeutics stock rose 8.66% during the day. Talphera and Akili also moved upwards. Losers include Biofrontera and Creative Medical Tech.
Benzinga · 03/07 21:31
Medicus Pharma appoints Erica Monaco as COO
Medicus Pharma appoints Erica Monaco as COO. Ms. Monaco is an accomplished C-suite professional with a successful track record in the pharmaceutical industry. The Co. Also announced that it has engaged Renmark Financial Communications to increase market and brand awareness. Medicus Pharma Ltd. (MDCX:CA)
Seeking Alpha · 03/05 12:46
Weekly Report: what happened at BFRI last week (0226-0301)?
Weekly Report · 03/04 11:59
12 Health Care Stocks Moving In Friday's After-Market Session
Ainos (NASDAQ:AIMD) stock moved upwards by 54.3% to $1.62 during Friday's after-market session. Aadi Bioscience and Taysha Gene Therapies stock also rose during the session. Losers Healthcare Triangle stock fell 8.1% during the same time period.
Benzinga · 03/01 21:32
Weekly Report: what happened at BFRI last week (0219-0223)?
Weekly Report · 02/26 12:17
More
Webull provides a variety of real-time BFRI stock news. You can receive the latest news about Biofrontera Inc through multiple platforms. This information may help you make smarter investment decisions.
About BFRI
Biofrontera Inc. is a biopharmaceutical company. The Company is focused on commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its principal licensed product is Ameluz, which is a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy. In the United States, the PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses (AK) of mild-to-moderate severity on the face and scalp. Its second prescription drug licensed product in its portfolio is Xepi, which is a topical non-fluorinated quinolone that inhibits bacterial growth and used for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes.